Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
BIDU-SW
09888
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -3.93%33.44B | 0.20%138.18B | 4.03%34.81B | -1.13%137.91B | -4.34%34.02B | 0.56%36.34B | -4.18%34.1B | 3.87%33.46B | 9.29%139.49B | 5.35%35.56B |
| Cost of revenue | -4.90%23.93B | -0.53%99.55B | 2.58%25.16B | -3.90%100.08B | -8.69%24.52B | -3.34%26.2B | -7.26%24.82B | 4.78%24.53B | 12.50%104.14B | 9.53%26.86B |
| Gross profit | -1.41%9.51B | 2.10%38.63B | 8.04%9.65B | 7.02%37.84B | 9.13%9.49B | 12.25%10.14B | 5.16%9.28B | 1.43%8.93B | 0.82%35.36B | -5.77%8.7B |
| Operating expense | 4.17%7.32B | 4.76%28.42B | 6.79%7.03B | 2.81%27.13B | 2.24%6.84B | 5.54%6.97B | 3.63%6.73B | -0.17%6.58B | 2.61%26.39B | 1.64%6.69B |
| Selling and administrative expenses | 4.17%7.32B | 4.76%28.42B | 6.79%7.03B | 2.81%27.13B | 2.24%6.84B | 5.54%6.97B | 3.63%6.73B | -0.17%6.58B | 2.61%26.39B | 1.64%6.69B |
| -Selling and marketing expense | 2.22%4.6B | 2.06%17.48B | 9.29%4.5B | 0.04%17.13B | -1.74%4.24B | 7.95%4.44B | -2.39%4.33B | -3.27%4.11B | 1.63%17.12B | 2.25%4.32B |
| -General and administrative expense | 7.61%2.73B | 9.40%10.94B | 2.63%2.54B | 7.92%10B | 9.49%2.6B | 1.56%2.53B | 16.63%2.4B | 5.47%2.47B | 4.45%9.27B | 0.55%2.37B |
| Operating profit | -16.39%2.19B | -4.64%10.21B | 11.55%2.62B | 19.40%10.71B | 31.98%2.66B | 30.54%3.16B | 9.42%2.54B | 6.20%2.35B | -4.09%8.97B | -24.14%2.01B |
| Net non-operating interest income (expenses) | -30.12%58M | 12.27%311M | 23.88%83M | 130.83%277M | 68.89%76M | 89.19%70M | 166.67%64M | 378.57%67M | 531.58%120M | 462.50%45M |
| Non-operating interest income | -9.30%78M | 15.49%343M | 19.44%86M | 103.42%297M | 51.92%79M | 60.42%77M | 146.43%69M | 300.00%72M | 231.82%146M | 246.67%52M |
| Non-operating interest expense | 566.67%20M | 60.00%32M | -40.00%3M | -23.08%20M | -57.14%3M | -36.36%7M | 25.00%5M | 25.00%5M | 4.00%26M | 0.00%7M |
| Net investment income | -13.61%533M | -24.56%995M | -8.05%617M | 11.97%1.32B | 510.87%189M | 24.79%302M | -34.85%157M | -9.45%671M | -2.00%1.18B | -159.74%-46M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -46M | 84.99%3.49B | 0 | 216.44%1.89B | 2,376.67%683M | -68.05%200M | 418.26%596M | -126.79%-30M | ||
| Income from associates and other participating interests | -26.67%363M | 12.04%2B | 55.66%495M | 13.55%1.79B | 21.56%575M | 1.96%365M | 17.11%527M | 9.28%318M | 12.05%1.57B | 9.74%473M |
| Special income (charges) | -107.26%-23M | 74.65%-289M | 5,383.33%317M | -173.38%-1.14B | -75.00%-665M | -153.10%-60M | -501.47%-409M | 92.68%-6M | 63.36%-417M | 32.14%-380M |
| Less:Restructuring and mergern&acquisition | --0 | ---320M | ---320M | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Less:Other special charges | 666.67%23M | -40.00%609M | -50.00%3M | 222.22%1.02B | 94.24%540M | 153.10%60M | 501.47%409M | -92.68%6M | -72.32%315M | -50.36%278M |
| Less:Write off | ---- | --0 | ---- | 22.55%125M | ---- | ---- | ---- | ---- | --102M | ---- |
| Other non-operating income (expenses) | 20.42%171M | 4.34%577M | -2.74%142M | -2.12%553M | 6.72%143M | -1.36%145M | -4.80%119M | -8.18%146M | 6.20%565M | -4.29%134M |
| Income before tax | -24.11%3.24B | 12.40%17.3B | 20.58%4.27B | 22.28%15.39B | 65.43%3.66B | 6.11%4.19B | 29.30%4B | 6.30%3.54B | 9.56%12.58B | -22.73%2.21B |
| Income tax | -23.47%773M | 11.90%4.32B | 105.28%1.01B | 52.73%3.86B | 63.67%1.24B | 70.48%895M | 100.65%1.24B | -22.03%492M | 5.42%2.53B | -9.45%757M |
| Net income | -24.29%2.47B | 12.56%12.97B | 6.92%3.26B | 14.63%11.52B | 66.46%2.42B | -3.77%3.29B | 11.54%2.77B | 12.92%3.05B | 10.64%10.05B | -28.26%1.45B |
| Net income continuous operations | -24.31%2.47B | 12.57%12.97B | 6.92%3.26B | 14.62%11.52B | 66.35%2.42B | -3.77%3.29B | 11.54%2.77B | 12.92%3.05B | 10.65%10.05B | -28.21%1.45B |
| Noncontrolling interests | -85.71%2M | -27.91%31M | 40.00%14M | 53.57%43M | 0.00%14M | -20.00%8M | 650.00%11M | 66.67%10M | 75.00%28M | 1,300.00%14M |
| Net income attributable to the company | -24.05%2.47B | 12.71%12.94B | 6.81%3.25B | 14.53%11.48B | 66.99%2.4B | -3.70%3.28B | 11.01%2.75B | 12.80%3.04B | 10.54%10.02B | -28.87%1.44B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -24.05%2.47B | 12.71%12.94B | 6.81%3.25B | 14.53%11.48B | 66.99%2.4B | -3.70%3.28B | 11.01%2.75B | 12.80%3.04B | 10.54%10.02B | -28.87%1.44B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -22.41%86.9 | 13.57%450.25 | 6.39%112 | 14.16%396.46 | 66.20%82.875 | -4.06%113.315 | 10.54%95 | 12.76%105.27 | 10.55%347.28 | -28.84%49.865 |
| Diluted earnings per share | -22.41%86.9 | 13.57%450.25 | 6.39%112 | 14.16%396.46 | 66.24%82.875 | -4.09%113.2852 | 10.54%94.9659 | 12.76%105.27 | 10.55%347.28 | -28.85%49.8516 |
| Dividend per share | 0 | 8.00%135 | 0 | 21.95%125 | 13.04%65 | 0 | 33.33%60 | 0 | 36.67%102.5 | 43.75%57.5 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |